Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951537priorityCriticalpatent/ECSP951537A/en
Publication of ECSP951537ApublicationCriticalpatent/ECSP951537A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invención se refiere a una combinación farmacéutica de inhibidores de absorción de colesterol e inhibidores de síntesis de colesterol a equipos que contienen tales combinaciones y al uso de tales combinaciones para tratar hipercolesterolemia y aterosclerosis, en mamíferos.This invention relates to a pharmaceutical combination of cholesterol absorption inhibitors and cholesterol synthesis inhibitors to kits containing such combinations and to the use of such combinations to treat hypercholesterolemia and atherosclerosis, in mammals.
ECSP9515371995-09-201995-09-20
COMBINED THERAPY FOR HYPERCOLESTEROLEMIA
ECSP951537A
(en)
Composition for topical application to the skin pharmaceutical composition use of a cholesterol synthesis inhibitor and process for the treatment of mitigation or prevention of skin disorders
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISORDER OF DISABILITY OF ATTENTION AND DISORDER OF ATTENTION DISABILITY / HYPERACTIVITY WITH METHYLPHENIDATE